
Cell Culture Market Share, Growth, Upcoming Trends, Future Demand 2030
Cell Culture Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Published: Apr-2022 | Report ID: BIOT2213 | Pages: 1 - 223 | Formats*: |
Category : Biotechnology |
Report Metric | Details |
Market size available for years | 2019-2030 |
Base year considered | 2021 |
Forecast period | 2022-2030 |
Segments covered | By Product, By Application, By End User |
Geographies covered | North America, Europe, APAC, Latin America and the Middle East & Africa |
Companies Covered | Adolf Kühner AG, Agilent Technologies, Inc., ANGUS Chemical Company, Becton, Dickinson and Company, Biospherix Ltd., Caisson Laboratories Inc., Cellexus, Corning Incorporated, Danaher Corporation, Eppendorf AG, FUJIFILM Irvine Scientific, Inc., Getinge AB, HiMedia Laboratories, InvivoGen, Lonza Group AG, Meissner Filtration Products Inc., Merck KGaA, Miltenyi Biotec, Pan-Biotech GmbH, PromoCell GmbH, Sartorius AG, SeraCare Life Sciences Inc., Solida Biotech GmbH, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc. |
1.1. Scope of the report1.2. Market segment analysis
2.1. Research data source
2.1.1. Secondary data2.1.2. Primary data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impact of the Cell Culture Market
5.1. SWOT analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL analysis
5.2.1. Political landscape5.2.2. Economic landscape5.2.3. Social landscape5.2.4. Technological landscape5.2.5. Environmental landscape5.2.6. Legal landscape
5.3. PORTER’S five forces analysis
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of Buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat map analysis
6.1. Consumables
6.1.1. Sera, Media, and Reagents6.1.1.1. Media (serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other media)6.1.1.2. Sera (fetal bovine sera (FBS), adult bovine sera (ABS), and other animal sera)6.1.1.3. Reagents (growth factors, supplements, buffers & chemicals, cell dissociation reagents, balanced salt solutions, attachment & matrix factors, antibiotics/antimycotics, contamination detection kits, cryoprotective agents, and other reagents)6.1.2. Vessels6.1.2.1. Roller/Roux Bottles6.1.2.2. Cell Factory Systems/Cell Stacks6.1.2.3. Multiwell Plates6.1.2.4. Flasks6.1.2.5. Petri Dishes6.1.3. Accessories
6.2. Equipment
6.2.1. Supporting Equipment (filtration systems, cell counters, carbon dioxide incubators, centrifuges, autoclaves, microscopes, biosafety cabinets, and other supporting equipment such as pipetting aids, pipettes, cell inserts, cell scrapers, cell lifters, cell spreaders, pH meters, shakers, flow cytometers, and water baths)6.2.2. Bioreactors (conventional bioreactors, single-use bioreactors)
6.2.3. Storage Equipment (Refrigerators & freezers, Cryostorage systems)
7.1. Biopharmaceutical Production
7.1.1. Monoclonal antibodies7.1.2. Vaccines production7.1.3. Other therapeutic proteins
7.2. Diagnostics7.3. Drug Screening & Development7.4. Tissue Engineering & Regenerative Medicine
7.4.1. Cell and gene therapy7.4.2. Other tissue engineering & regenerative medicine applications
7.5. Other Applications
8.1. Pharmaceutical & Biotechnology Companies8.2. Hospitals & Diagnostic Laboratories8.3. Research & Academic Institutes8.4. Other End Users
9.1. North America
9.1.1. United States9.1.2. Canada9.1.3. Mexico
9.2. Europe
9.2.1. Germany9.2.2. United Kingdom9.2.3. France9.2.4. Italy9.2.5. Spain9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China9.3.2. Japan9.3.3. India9.3.4. Australia9.3.5. South Korea9.3.6. Rest of Asia-Pacific
9.4. South America
9.4.1. Brazil9.4.2. Argentina9.4.3. Rest of South America
9.5. Middle East & Africa
9.5.1. Kingdom of Saudi Arabia9.5.2. United Arab Emirates9.5.3. Rest of Middle East & Africa
10.1. Adolf Kühner AG
10.1.1. Company details10.1.2. Financial outlook10.1.3. Product summary10.1.4. Recent developments
10.2. Agilent Technologies, Inc.
10.2.1. Company details10.2.2. Financial outlook10.2.3. Product summary10.2.4. Recent developments
10.3. ANGUS Chemical Company
10.3.1. Company details10.3.2. Financial outlook10.3.3. Product summary10.3.4. Recent developments
10.4. Becton, Dickinson and Company
10.4.1. Company details10.4.2. Financial outlook10.4.3. Product summary10.4.4. Recent developments
10.5. Biospherix Ltd.
10.5.1. Company details10.5.2. Financial outlook10.5.3. Product summary10.5.4. Recent developments
10.6. Caisson Laboratories Inc.
10.6.1. Company details10.6.2. Financial outlook10.6.3. Product summary
10.6.4. Recent developments
10.7. Cellexus
10.7.1. Company details10.7.2. Financial outlook10.7.3. Product summary10.7.4. Recent developments
10.8. Corning Incorporated
10.8.1. Company details10.8.2. Financial outlook10.8.3. Product summary10.8.4. Recent developments
10.9. Danaher Corporation
10.9.1. Company details10.9.2. Financial outlook10.9.3. Product summary10.9.4. Recent developments
10.10. Eppendorf AG
10.10.1. Company details10.10.2. Financial outlook10.10.3. Product summary10.10.4. Recent developments
10.11. FUJIFILM Irvine Scientific, Inc.
10.11.1. Company details10.11.2. Financial outlook10.11.3. Product summary10.11.4. Recent developments
10.12. Getinge AB
10.12.1. Company details10.12.2. Financial outlook10.12.3. Product summary10.12.4. Recent developments
10.13. HiMedia Laboratories
10.13.1. Company details10.13.2. Financial outlook10.13.3. Product summary10.13.4. Recent developments
10.14. InvivoGen
10.14.1. Company details10.14.2. Financial outlook10.14.3. Product summary10.14.4. Recent developments
10.15. Lonza Group AG
10.15.1. Company details10.15.2. Financial outlook10.15.3. Product summary10.15.4. Recent developments
10.16. Meissner Filtration Products Inc.
10.16.1. Company details10.16.2. Financial outlook10.16.3. Product summary10.16.4. Recent developments
10.17. Merck KGaA
10.17.1. Company details10.17.2. Financial outlook10.17.3. Product summary
10.17.4. Recent developments
10.18. Miltenyi Biotec
10.18.1. Company details10.18.2. Financial outlook10.18.3. Product summary10.18.4. Recent developments
10.19. Pan-Biotech GmbH
10.19.1. Company details10.19.2. Financial outlook10.19.3. Product summary10.19.4. Recent developments
10.20. PromoCell GmbH
10.20.1. Company details10.20.2. Financial outlook10.20.3. Product summary10.20.4. Recent developments
10.21. Sartorius AG
10.21.1. Company details10.21.2. Financial outlook10.21.3. Product summary10.21.4. Recent developments
10.22. SeraCare Life Sciences Inc.
10.22.1. Company details10.22.2. Financial outlook10.22.3. Product summary10.22.4. Recent developments
10.23. Solida Biotech GmbH
10.23.1. Company details10.23.2. Financial outlook10.23.3. Product summary10.23.4. Recent developments
10.24. STEMCELL Technologies Inc.
10.24.1. Company details10.24.2. Financial outlook10.24.3. Product summary10.24.4. Recent developments
10.25. Thermo Fisher Scientific Inc.
10.25.1. Company details10.25.2. Financial outlook10.25.3. Product summary10.25.4. Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.